GE Healthcare Launches low cost Cardiac solutions for India

GE CEOs launch cardiac ultrasound systems in India. 

GE Healthcare recently unveiled two advanced cardiac-care solutions designed and developed in India for India with the aim to provide better, affordable early cardiac diagnosis. The GE MAC 600 and GE VIVID P3 devices were developed as part of GE’s healthymagination programme.

“When we launched healthymagination two years ago, our vision was to provide better health for more people at lower costs,” said John Dineen, President and CEO, GE Healthcare, as he unveiled the ultrasound systems for cardiac care at Bangalore. “Through the use of powerful technology, innovation and the talent of our people, we are addressing global healthcare needs: reducing costs, increasing access and improving quality in real and relevant ways.  We are tremendously proud of our initial achievements: 29 healthymagination validated products, US$700 million in research and development investment and more than 135 million lives touched in new ways in the first two years.”

In India, healthymagination also means using local knowledge and expertise to develop the best medical technologies in the world,  added Dineen. “Some of these are local technologies and solutions, which will exclusively serve the Indian market. Other inventions will be exported to doctors and health systems around the world. Two great examples are the devices we are launching today: the GE Healthcare MAC 600 ECG and GE Vivid P3 ultrasound system,” said Dineen.

Also speaking at the event, Mr. V Raja, President and CEO, GE Healthcare, India, announced that the company is taking a bold step to equip every primary physician in India with the resources to wage war against cardiac disease.  “We plan to roll out a free, mass-scale online ECG training for primary care physicians in India as well as enhance our reach in tier II and III towns.  With ECG training and affordable innovations like GE MAC and Vivid cardiac ultrasound systems, healthcare providers are better prepared for early detection and cost effective treatment of cardiac disease.”

Enhanced by Zemanta
Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Your email address will not be published. Required fields are marked *